PUMA BIOTECHNOLOGY INC
Compare this stock
PBYI Stock Report Card
$
51%
Performance
Score:
100/100
PBYI returned 4.80% in the last 12 months. Based on SPY's performance of -21.18%, its performance is above average giving it a score of 100 of 100.
Analyst Price Targets
Score:
83/100
9 analysts offer 12-month price targets for PBYI. Together, they have an average target of 0, the most optimistic target put PBYI at 0 within 12-months and the most pessimistic has PBYI at 0.
Sentiment
Score:
65/100
PBYI had a bullish sentiment score of 65.49% across Twitter and StockTwits over the last 12 months. It had an average of 5.77 posts, 2.74 comments, and 4.22 likes per day.
Technicals
Score:
36/100
PBYI receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
Score:
10/100
PBYI has missed earnings 6 times in the last 20 quarters.
Profit
Score:
34/100
Out of the last 20 quarters, PBYI has had 6 profitable quarters and has increased their profits year over year on 5 of them.
Volatility
Score:
48/100
PBYI has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.
PUMA BIOTECHNOLOGY INC Summary
Nasdaq / PBYI
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
PBYI scored highly on our reportcard. Here are some similar companies and how they performed.
